Clinical trial
AMISH: Aprovel for Management of Isolated Systolic Hypertension
NCT00264212 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00264212 |
|---|---|
| Title | AMISH : Aprovel for Management of Isolated Systolic Hypertension |
| Official title | A Multicentre Prospective Randomized Open-Label 12-Week Study With Blinded Evaluation Comparing the Efficacy and Safety of Irbesartan and Irbesartan-Hydrochlorothiazide Fixed Combination With Amlodipine and Amlodipine Plus Hydrochlorothiazide in Elderly Patients With Isolated Systolic Hypertension |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | irbesartan and irbesartan-hydrochlorothiazide |
| Enrollment | 436 |
| Start date | Aug 1, 2004 |
| First posted | Dec 12, 2005 |
| Last update posted | Dec 21, 2007 |
| Countries | Chile, China, Indonesia, Mexico, Philippines, South Korea, Taiwan, Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: